|Min SIP Amount||₹500|
|NAV||₹104.66 (03 Aug 2020)|
|Fund Started||31 Mar 2000|
|Fund Size||₹10 Cr|
|Strides Pharma Science Ltd.||Healthcare||Equity||7.8%|
|Neuland Laboratories Ltd.||Healthcare||Equity||7.4%|
|Bharti Airtel Ltd.||Communication||Equity||6.7%|
|BASF India Ltd.||Chemicals||Equity||6.7%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||6.0%|
|Hindustan Unilever Ltd.||FMCG||Equity||5.7%|
|Sumitomo Chemical India Pvt. Ltd.||Others||Equity||4.7%|
|Rallis India Ltd.||Chemicals||Equity||3.3%|
|Godrej Agrovet Ltd.||FMCG||Equity||3.3%|
Quant Tax Plan Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 31 Mar 2000. Sanjeev Sharma is the Current Fund Manager of Quant Tax Plan Growth fund.The fund currently has an Asset Under Management(AUM) of ₹10 Cr and the Latest NAV as of 03 Aug 2020 is ₹104.66.
The Quant Tax Plan Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500.
A tax planning scheme aims to provide tax benefits along with capital appreciation by investing predominantly in a well diversified portfolio of Equity Shares with growth potential. This income may be complemented by possible dividend and other income.
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.